keytruda plus chemotherapy improves progression-free survival in metastatic breast cancer
Published 4 years ago • 695 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
1:53
#pembrolizumab (keytruda) plus #chemotherapy in metastatic non-small cell #lungcancer (nsclc)
-
5:13
immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
1:56
next questions in breast cancer treatment
-
1:58
progression free survival in advanced melanoma improved by cell therapy
-
1:56
immunotherapy plus chemotherapy combination for advanced lung cancer improves and prolongs life
-
2:00
tulip: trastuzumab duocarmazine improved pfs in pre-treated her2 breast cancer
-
2:27
capivasertib fulvestrant improves progression-free survival in advanced hr breast cancer patients
-
1:06
padcev, keytruda combination proves impactful for patients with metastatic urothelial cancer
-
5:08
combination of capecitabine and bevacizumab improves progression-free survival in breast cancer
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
2:06
elacestrant significantly prolongs pfs for er /her2- metastatic bc without prior chemotherapy pts
-
3:47
parp inhibitory velaparib trialled in brca1/2 breast cancer